| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |